Adsorbed COVID-19 (inactivated) Vaccine

BIOLOGICAL4 trials

Sponsors

Butantan Institute, D'Or Institute for Research and Education

Conditions

COVID-19Covid19SARS-CoV-2 Acute Respiratory Disease

Phase 3

Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals

CompletedNCT04456595

Butantan InstituteCOVID-19

Start: 2020-07-21End: 2022-02-17Updated: 2024-02-15

Phase 4

An Effectiveness Study of the Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine

CompletedNCT04747821

Butantan InstituteCovid19

Start: 2021-02-07End: 2023-07-20Updated: 2024-02-15

A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19

D'Or Institute for Research and EducationCOVID-19

Start: 2021-02-19End: 2023-06-30Updated: 2021-07-09

Unknown Phase

Active Pharmacovigilance Study of Adsorbed COVID-19 (Inactivated) Vaccine

CompletedNCT04845048

Butantan InstituteSARS-CoV-2 Acute Respiratory Disease

Start: 2021-05-10End: 2023-03-13Updated: 2023-05-22

Related Papers

Indirect protection and long-term effectiveness of inactivated COVID-19 vaccine: a stepped-wedge randomised trial in Serrana, Brazil

Scientific Reports2026-02-19

Long-term efficacy and immune response of CoronaVac in Brazilian health care workers: Insights from PROFISCOV unblinded trial

Vaccine2025-07-28

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.

2020-11-171006 citations